Neurocognitive and genetic influences on Eating Disorder and Substance Use Disorder comorbidity in individuals from families enriched with Substance Use Disorders
Name:
Singman_dzov_Dissertation (1).pdf
Size:
2.771Mb
Format:
PDF
Description:
Doctoral Dissertation
Readers/Advisors
Meyers, JacquelynTerm and Year
Spring 2024Date Published
2024-06-05Metadata
Show full item recordAbstract
Eating disorders (EDs), including anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED) have the highest mortality of all psychiatric disorders with no pharmacological treatment approved for AN in adults nor for any ED in children and adolescents. The prevalences of AN, BN, and BED range from 1-5% and differ between age groups, by sex, and between people of different races/ethnicities. Additionally, eating disorders are often comorbid with substance use disorders (SUDs), complicating treatment and increasing morbidity and mortality. The comorbidity of EDs and SUDs, which has been shown to be more likely in the case of EDs with binge behavior, suggests that other factors, such as neurocognitive, neurobiological, and genetic influences may underlie both disorders. However, no previous work has examined the influence of these factors together. This dissertation study aims to investigate the influence of neurophysiological and neuropsychological function as well as polygenic risk scores on the risk for EDs and co-occurring SUDs. This research will be carried out using data from the Collaborative Study on the Genetics of Alcoholism (COGA) (N= 15,221), a deeply characterized sample of families densely affected with AUD and community comparison families. Overall, the findings from this dissertation demonstrate the importance of considering epidemiological, neurocognitive, neurobiological, and genetic factors together when investigating influences of risk for EDs and co-occurring SUDs. These findings show that the comorbidity of EDs and AUD is especially likely in BN and BED across gender and racial groups, and that females and White individuals are at greater risk of to AN-AUD comorbidity. The necessity of screening Black individuals for developing EDs and comorbid AUD is highlighted, especially in the case of binge-type EDs, due to increased BED prevalence and seemingly equal risk of AUD comorbidity in this population. The findings suggest that AN symptoms may relate to better cognitive performance in specific areas of executive function, especially in females, and that decreased P3 amplitude and increased beta EEG coherence may serve as endophenotypes for the binge-type EDs. Increased beta coherence may be a factor underlying both EDs and SUDs, with males and females showing different coherence patterns. Finally, polygenic risk for EDs may relate to neurocognitive and neurophysiological differences seen in EDs, with more statistical genetic research necessary for BN and BED, and more representative samples needed for all EDs. This work points to the potential benefit of a neuropsychiatric approach, encompassing both epidemiological factors as well as assessment of executive function, P3 amplitude, and beta EEG coherence, in the screening for and management of EDs and comorbid SUDs.Citation
Singman, D. (2024). Neurocognitive and genetic influences on Eating Disorder and Substance Use Disorder comorbidity in individuals from families enriched with Substance Use Disorders. [Doctoral dissertation, SUNY Downstate Health Sciences University]. SUNY Open Access Repository. https://soar.suny.edu/handle/20.500.12648/15864Description
Doctoral DissertationRelated items
Showing items related by title, author, creator and subject.
-
Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventureNeuroimaging has been extensively used to study brain structure and function in individuals with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) over the past decades. Two of the main shortcomings of the neuroimaging literature of these disorders are the small sample sizes employed and the heterogeneity of methods used. In 2013 and 2014, the ENIGMA-ADHD and ENIGMA-ASD working groups were respectively, founded with a common goal to address these limitations. Here, we provide a narrative review of the thus far completed and still ongoing projects of these working groups. Due to an implicitly hierarchical psychiatric diagnostic classification system, the fields of ADHD and ASD have developed largely in isolation, despite the considerable overlap in the occurrence of the disorders. The collaboration between the ENIGMA-ADHD and -ASD working groups seeks to bring the neuroimaging efforts of the two disorders closer together. The outcomes of case–control studies of subcortical and cortical structures showed that subcortical volumes are similarly affected in ASD and ADHD, albeit with small effect sizes. Cortical analyses identified unique differences in each disorder, but also considerable overlap between the two, specifically in cortical thickness. Ongoing work is examining alternative research questions, such as brain laterality, prediction of case–control status, and anatomical heterogeneity. In brief, great strides have been made toward fulfilling the aims of the ENIGMA collaborations, while new ideas and follow-up analyses continue that include more imaging modalities (diffusion MRI and resting-state functional MRI), collaborations with other large databases, and samples with dual diagnoses.
-
Characteristics of Adults with Attention Deficit Hyperactivity Disorder Plus Substance Use Disorder: The Role of Psychiatric ComorbidityThe objective of the study was to investigate the characteristics of adults with Attention Deficit Hyperactivity Disorder (ADHD) or substance use disorder (SUD), especially in the context of comorbid psychiatric disorders. Subjects were adults (n ¼ 78) participating in a controlled family study of ADHD and SUD. Four groups were identified based on a diagnosis of ADHD or SUD: ADHD, SUD, ADHDþSUD, and neither ADHD nor SUD. All diagnoses were determined by structured clinical interview for DSM IV. Rates of psychiatric comorbidity were lowest in the controls, intermediate in the ADHD and SUD groups, and highest in the ADHDþSUD group. Relative to controls, the ADHD, SUD, and ADHDþSUD groups had higher rates of major depression (z ¼ 1.98, p ¼ 0.05), conduct disorder (z ¼ 2.0, p ¼ 0.04), antisocial personality disorder (z ¼ 2.6, p ¼ 0.009), agoraphobia (z ¼ 2.5, p ¼ 0.01) and social phobia (z ¼ 2.7, p ¼ 0.007). Higher rates of psychiatric comorbidity, especially mood and anxiety disorders, exist in subjects with SUDþADHD relative to subjects with SUD, ADHD, or controls. Clinicians need to be attentive to other psychiatric disorders that may occur in the large group of adults with ADHDþSUD.
-
Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorderAttention-Deficit/Hyperactivity Disorder (ADHD) is a childhood psychiatric disorder often comorbid with disruptive behavior disorders (DBDs). Here, we report a GWAS meta-analysis of ADHD comorbid with DBDs (ADHD + DBDs) including 3802 cases and 31,305 controls. We identify three genome-wide significant loci on chromosomes 1, 7, and 11. A meta-analysis including a Chinese cohort supports that the locus on chromosome 11 is a strong risk locus for ADHD + DBDs across European and Chinese ancestries (rs7118422, P = 3.15×10-10, OR = 1.17). We find a higher SNP heritability for ADHD + DBDs (h2SNP = 0.34) when compared to ADHD without DBDs (h2SNP = 0.20), high genetic correlations between ADHD + DBDs and aggressive (rg = 0.81) and anti-social behaviors (rg = 0.82), and an increased burden (polygenic score) of variants associated with ADHD and aggression in ADHD + DBDs compared to ADHD without DBDs. Our results suggest an increased load of common risk variants in ADHD + DBDs compared to ADHD without DBDs, which in part can be explained by variants associated with aggressive behavior.
